Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance
Author:
Affiliation:
1. Department of Endocrinology and Metabolism; Tohto Clinic; Tokyo Japan
Publisher
Wiley
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12781/fullpdf
Reference15 articles.
1. Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus;Scheen;Drugs,2015
2. SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials;Inzucchi;Diab Vasc Dis Res,2015
3. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
4. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance;Iozzo;Diabetes,2002
5. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC;Okazaki;Clin Chim Acta,2000
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review;American Journal of Kidney Diseases;2024-05
2. Remnant cholesterol, iron status and diabetes mellitus: a dose–response relationship and mediation analysis;Diabetology & Metabolic Syndrome;2024-03-12
3. Judicious use of modern technology with antihyperglycemic agents: The changing landscape of type 2 diabetes management;Journal of Diabetology;2024-01
4. Association of remnant cholesterol and newly diagnosed early‐onset type 2 diabetes mellitus in Chinese population: A retrospective cross‐sectional study;Journal of Diabetes;2023-11-14
5. Remnant cholesterol in atherosclerotic cardiovascular disease: A systematic review and meta-analysis;Hellenic Journal of Cardiology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3